Change in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous Obliteration

Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gut and liver Ročník 14; číslo 6; s. 783 - 791
Hlavní autoři: Park, Jae Woo, Yoo, Jeong-Ju, Kim, Sang Gyune, Jeong, Soung Won, Jang, Jae Young, Lee, Sae Hwan, Kim, Hong Soo, Lee, Jae Myung, Shim, Jong Joon, Kim, Young Don, Cheon, Gab Jin, Jun, Baek Gyu, Kim, Young Seok
Médium: Journal Article
Jazyk:angličtina
Vydáno: Korea (South) Editorial Office of Gut and Liver 01.11.2020
Gastroenterology Council for Gut and Liver
거트앤리버 소화기연관학회협의회
Témata:
ISSN:1976-2283, 2005-1212, 2005-1212
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO. From March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO. The analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021). Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037). The artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration. Portal pressure measurement is helpful for predicting the patient's clinical outcome.
AbstractList Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO. From March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO. The analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021). Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037). The artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration. Portal pressure measurement is helpful for predicting the patient's clinical outcome.
Background/Aims: Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO. Methods: From March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO. Results: The analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021). Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037). Conclusions: The artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration. Portal pressure measurement is helpful for predicting the patient’s clinical outcome.
Background/Aims: Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO. Methods: From March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO. Results: The analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021). Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037). Conclusions: The artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration. Portal pressure measurement is helpful for predicting the patient’s clinical outcome. KCI Citation Count: 0
Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO.Background/AimsPlug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO. The aim of this study was to determine the changes in portal pressure and the associated changes in liver function, ascites, hepatic encephalopathy, and especially esophageal varix (EV) after PARTO.From March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO.MethodsFrom March 2012 to February 2018, 54 patients who underwent PARTO were analyzed retrospectively. The parameters collected included liver function and episodes of cirrhotic complications before and at 1 and 6 months after PARTO.The analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021). Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037).ResultsThe analysis of 54 patients showed improvement in liver function during the 6-month follow-up period (Model for End-Stage Liver Disease score: change from 11.46±4.35 to 10.33±2.96, p=0.021). Among these 54 patients, 25 patients were evaluated for their hepatic venous pressure gradient (HVPG) before and after PARTO (change from 12.52±3.83 to 14.68±5.03 mm Hg; p<0.001). Twenty-five patients with portal pressure measured before and after PARTO were evaluated for risk factors affecting liver function improvement and EV deterioration. No factor associated with portal pressure was affected by liver function improvement. Post-PARTO portal pressure was a risk factor affecting EV deterioration (HVPG-post: odds ratio, 1.341; 95% confidence interval, 1.017 to 1.767; p=0.037).The artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration. Portal pressure measurement is helpful for predicting the patient's clinical outcome.ConclusionsThe artificial blockade of the portosystemic shunt evidently leads to an increase in HVPG. Liver function was improved over the 6-month follow-up period. Portal pressure after PARTO was a significant risk factor for EV deterioration. Portal pressure measurement is helpful for predicting the patient's clinical outcome.
Author Park, Jae Woo
Kim, Sang Gyune
Jeong, Soung Won
Lee, Sae Hwan
Shim, Jong Joon
Yoo, Jeong-Ju
Jun, Baek Gyu
Lee, Jae Myung
Kim, Hong Soo
Kim, Young Don
Cheon, Gab Jin
Kim, Young Seok
Jang, Jae Young
AuthorAffiliation 1 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
4 Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
5 Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
3 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
AuthorAffiliation_xml – name: 4 Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
– name: 1 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
– name: 5 Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
– name: 2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
– name: 3 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
Author_xml – sequence: 1
  givenname: Jae Woo
  orcidid: 0000-0002-6531-2481
  surname: Park
  fullname: Park, Jae Woo
  organization: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
– sequence: 2
  givenname: Jeong-Ju
  orcidid: 0000-0002-7802-0381
  surname: Yoo
  fullname: Yoo, Jeong-Ju
  organization: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
– sequence: 3
  givenname: Sang Gyune
  orcidid: 0000-0001-8694-777X
  surname: Kim
  fullname: Kim, Sang Gyune
  organization: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
– sequence: 4
  givenname: Soung Won
  orcidid: 0000-0003-2855-6011
  surname: Jeong
  fullname: Jeong, Soung Won
  organization: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Jae Young
  orcidid: 0000-0001-5335-752X
  surname: Jang
  fullname: Jang, Jae Young
  organization: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Sae Hwan
  orcidid: 0000-0001-8320-5914
  surname: Lee
  fullname: Lee, Sae Hwan
  organization: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
– sequence: 7
  givenname: Hong Soo
  orcidid: 0000-0003-3966-9302
  surname: Kim
  fullname: Kim, Hong Soo
  organization: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
– sequence: 8
  givenname: Jae Myung
  orcidid: 0000-0003-4094-5239
  surname: Lee
  fullname: Lee, Jae Myung
  organization: Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
– sequence: 9
  givenname: Jong Joon
  orcidid: 0000-0003-0578-9824
  surname: Shim
  fullname: Shim, Jong Joon
  organization: Department of Radiology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
– sequence: 10
  givenname: Young Don
  orcidid: 0000-0001-9003-9862
  surname: Kim
  fullname: Kim, Young Don
  organization: Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
– sequence: 11
  givenname: Gab Jin
  orcidid: 0000-0001-5937-5999
  surname: Cheon
  fullname: Cheon, Gab Jin
  organization: Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
– sequence: 12
  givenname: Baek Gyu
  orcidid: 0000-0003-4693-9542
  surname: Jun
  fullname: Jun, Baek Gyu
  organization: Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
– sequence: 13
  givenname: Young Seok
  orcidid: 0000-0002-7113-3623
  surname: Kim
  fullname: Kim, Young Seok
  organization: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32050751$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002647118$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNplUtFuFCEUJabGtquJX2B41IepwAwwvJhsNlo3abKbZvWVAMPM0s5CBabGz_CPpbvdauMLNxzOPedy7z0HJz54C8BbjC4oQuLj4EcsiKhfgDOCEK0wweQEnGHBWUVIW5-C85RuEGKYcPoKnNYEUcQpPgO_F1vlBwudh-sQsxrhOtqUpmih8h1cjM47U9DVlE3Y7XkLF-M2ZGfgWmVnfU7wp8tbeKlSjgX9rsppE1R9thGux2mo5im5lG0Hr22OYYiqs3ATlU_31ocpwZUeXSEXueBfg5e9GpN98xhn4NuXz5vF1-pqdblczK8q03CSK44UpoiKVpCmpr2phWIt10R05dZy2nDdMMN6jrAVTa21Qm1PCVGdID2p-3oGPhx0fezlrXEyKLePQ5C3Uc6vN0spGKKcoMJdHrhdUDfyLrqdir_2CXsgxEGqWDoyWkl1r43WbYeYaAjSQvUtEtigmjDTEFW0Ph207ia9s50pDYxqfCb6_MW7banpXnLGuCjDnIH3jwIx_JhsynLnkrHjqLwtzZSkLp-vGecPdb_71-vJ5Dj_Qrg4EEwMKUXbS-PyfgzF2o0SI_mwYPK4YH_NnxKOmv9R_wAnstH7
CitedBy_id crossref_primary_10_1177_20503121231208655
crossref_primary_10_1111_jgh_16280
crossref_primary_10_1007_s10140_024_02232_2
crossref_primary_10_1055_s_0044_1786794
crossref_primary_10_3390_gidisord6030050
crossref_primary_10_1038_s41598_024_63848_5
crossref_primary_10_1007_s00330_025_11831_7
Cites_doi 10.1016/S1051-0443(07)61912-5
10.1111/j.1440-1746.1996.tb00010.x
10.1111/j.1572-0241.1999.00928.x
10.1148/radiol.13122102
10.3348/kjr.2003.4.2.109
10.1016/S0016-5107(86)71843-9
10.1007/s00535-007-2077-1
10.1055/s-0031-1284453
10.2214/AJR.07.2266
10.3350/cmh.2017.0064
10.2214/ajr.184.4.01841340
10.1111/j.1440-1746.2011.06835.x
10.1007/s002709900206
10.1007/s00261-004-0270-8
10.4253/wjge.v6.i5.168
10.3348/kjr.2016.17.2.230
10.1111/j.1440-1746.2008.05651.x
10.3350/cmh.2012.18.4.368
10.3748/wjg.v22.i11.3212
10.1097/01.RVI.0000186958.59457.10
10.1016/j.jvir.2009.11.023
10.1155/2014/391420
10.1016/j.jvir.2015.07.011
10.1007/s00270-013-0809-6
10.1002/hep.1840160607
10.1111/j.1440-1746.2010.06262.x
ContentType Journal Article
Copyright Copyright © 2020 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. 2020
Copyright_xml – notice: Copyright © 2020 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. 2020
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
ACYCR
DOI 10.5009/gnl19293
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-1212
EndPage 791
ExternalDocumentID oai_kci_go_kr_ARTI_9605720
oai_doaj_org_article_5bfbcbb8d069420b9af8091c0326c42a
PMC7667928
32050751
10_5009_gnl19293
Genre Journal Article
GroupedDBID ---
5-W
8JR
AAKDD
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
F5P
GROUPED_DOAJ
GX1
HYE
HZB
OK1
RPM
9ZL
M~E
NPM
7X8
5PM
53G
85H
ID FETCH-LOGICAL-c472t-70a15059892435fc39a687b29d35f87547b46c6f701e943bba08f522ad92f23f3
IEDL.DBID DOA
ISICitedReferencesCount 10
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000591659600012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1976-2283
2005-1212
IngestDate Tue Nov 21 21:39:36 EST 2023
Mon Nov 10 04:20:16 EST 2025
Tue Nov 04 02:00:26 EST 2025
Sun Nov 09 14:12:29 EST 2025
Thu Jan 02 22:59:30 EST 2025
Sat Nov 29 01:46:42 EST 2025
Tue Nov 18 21:02:49 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Therapeutic embolization
Portal pressure
Liver cirrhosis
Gastric varices
Gelatin sponge
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c472t-70a15059892435fc39a687b29d35f87547b46c6f701e943bba08f522ad92f23f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6531-2481
0000-0003-2855-6011
0000-0001-8694-777X
0000-0001-8320-5914
0000-0003-4094-5239
0000-0003-4693-9542
0000-0002-7802-0381
0000-0001-5335-752X
0000-0003-0578-9824
0000-0001-5937-5999
0000-0003-3966-9302
0000-0001-9003-9862
0000-0002-7113-3623
OpenAccessLink https://doaj.org/article/5bfbcbb8d069420b9af8091c0326c42a
PMID 32050751
PQID 2354736770
PQPubID 23479
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9605720
doaj_primary_oai_doaj_org_article_5bfbcbb8d069420b9af8091c0326c42a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7667928
proquest_miscellaneous_2354736770
pubmed_primary_32050751
crossref_citationtrail_10_5009_gnl19293
crossref_primary_10_5009_gnl19293
PublicationCentury 2000
PublicationDate 2020-11-01
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 2020-11-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Gut and liver
PublicationTitleAlternate Gut Liver
PublicationYear 2020
Publisher Editorial Office of Gut and Liver
Gastroenterology Council for Gut and Liver
거트앤리버 소화기연관학회협의회
Publisher_xml – name: Editorial Office of Gut and Liver
– name: Gastroenterology Council for Gut and Liver
– name: 거트앤리버 소화기연관학회협의회
References ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref21
  doi: 10.1016/S1051-0443(07)61912-5
– ident: ref6
  doi: 10.1111/j.1440-1746.1996.tb00010.x
– ident: ref7
  doi: 10.1111/j.1572-0241.1999.00928.x
– ident: ref19
  doi: 10.1148/radiol.13122102
– ident: ref25
  doi: 10.3348/kjr.2003.4.2.109
– ident: ref5
  doi: 10.1016/S0016-5107(86)71843-9
– ident: ref22
  doi: 10.1007/s00535-007-2077-1
– ident: ref1
  doi: 10.1055/s-0031-1284453
– ident: ref9
  doi: 10.2214/AJR.07.2266
– ident: ref3
  doi: 10.3350/cmh.2017.0064
– ident: ref8
  doi: 10.2214/ajr.184.4.01841340
– ident: ref13
– ident: ref14
  doi: 10.1111/j.1440-1746.2011.06835.x
– ident: ref26
  doi: 10.1007/s002709900206
– ident: ref17
  doi: 10.1007/s00261-004-0270-8
– ident: ref4
  doi: 10.4253/wjge.v6.i5.168
– ident: ref11
  doi: 10.3348/kjr.2016.17.2.230
– ident: ref28
  doi: 10.1111/j.1440-1746.2008.05651.x
– ident: ref10
  doi: 10.3350/cmh.2012.18.4.368
– ident: ref20
  doi: 10.3748/wjg.v22.i11.3212
– ident: ref16
  doi: 10.1097/01.RVI.0000186958.59457.10
– ident: ref18
  doi: 10.1016/j.jvir.2009.11.023
– ident: ref27
  doi: 10.1155/2014/391420
– ident: ref15
  doi: 10.1016/j.jvir.2015.07.011
– ident: ref23
  doi: 10.1007/s00270-013-0809-6
– ident: ref2
  doi: 10.1002/hep.1840160607
– ident: ref24
  doi: 10.1111/j.1440-1746.2010.06262.x
– ident: ref12
SSID ssj0061275
Score 2.2586603
Snippet Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal...
Background/Aims: Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 783
SubjectTerms gastric varices
gelatin sponge
liver cirrhosis
Original
portal pressure
therapeutic embolization
내과학
Title Change in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous Obliteration
URI https://www.ncbi.nlm.nih.gov/pubmed/32050751
https://www.proquest.com/docview/2354736770
https://pubmed.ncbi.nlm.nih.gov/PMC7667928
https://doaj.org/article/5bfbcbb8d069420b9af8091c0326c42a
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002647118
Volume 14
WOSCitedRecordID wos000591659600012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Gut and Liver, 2020, 14(6), , pp.783-791
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2005-1212
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0061275
  issn: 1976-2283
  databaseCode: DOA
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagQogL4t3lURmExClq1vHzCBUFDrQrBGhvlp_bqKssymb7P_jHjO3sqosqceEUJXEix_Ml803s-Qaht1QGxcARVIFbVtFpCJV11FfRexOctIz6OhebEGdncj5Xs2ulvtKasCIPXAbumNlonbXSpwxNUltlogQf52rgHY6STI2A9WyDqfIN5km2PM8nC14lgZciO8uAUBwvuiWwGtXsOaKs1w_upevjTVTz7xWT11zQ6QN0f-SO-H3p80N0K3SP0N2v4-z4Y_S7pArgtsNlgSguyX99wKbzeJQAXeLzzQA4y-1O2r6_WMH98KwIrK5x-jOLP5lUz8PhnyaJDq1xLiWOZ8vNogKDJmh4_C0MeXGXDzh7vKss94rPbUlrThZ_gn6cfvx-8rkaSy5UjgoyVKI2wBCZkhCWNSy6RhkuhSXKwx6ENlRYyh2Pop4GRRtrTS0jUDjjFYmkic1TdNCtunCIMDdEBusikIyQ5vBlYHAvC15TxobROEHvtuOv3ahHnspiLDXEJclSemupCXq9a_mraHDc0OZDMuHufFLNzgcAS3rEkv4XliboDQBAX7o2X5-2i5W-7DXEFl80xHpMkBp6s8WHhlcxza-YLsD4atKkQs5cCGjzrOBl15-G1MC82XSCxB6S9jq8f6ZrL7Lct-BcKCKf_48nfIHukfTDICdTvkQHQ78Jr9AddzW06_4I3RZzeZTfpD-viCTW
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Change+in+Portal+Pressure+and+Clinical+Outcome+in+Cirrhotic+Patients+with+Gastric+Varices+after+Plug-Assisted+Retrograde+Transvenous+Obliteration&rft.jtitle=Gut+and+liver&rft.au=Park%2C+Jae+Woo&rft.au=Yoo%2C+Jeong-Ju&rft.au=Kim%2C+Sang+Gyune&rft.au=Jeong%2C+Soung+Won&rft.date=2020-11-01&rft.issn=1976-2283&rft.eissn=2005-1212&rft.volume=14&rft.issue=6&rft.spage=783&rft.epage=791&rft_id=info:doi/10.5009%2Fgnl19293&rft.externalDBID=n%2Fa&rft.externalDocID=10_5009_gnl19293
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1976-2283&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1976-2283&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1976-2283&client=summon